ARCHIVES OCT 17 > 2014 Annual Scientific Meeting > 2014 ASM Syllabus > 2014 ASM Day 2 Agenda

TECHNOTOX: The Intersection of Technology & Toxicology

March 28-30, 2014, Arizona Biltmore Resort, Phoenix, AZ

Day 2 - Web-based Syllabus


Lecture slides are available as PDFs in color (1 slide per page) and black & white (3 slides per page). Only material submitted by the lecturer is available.The files contained on these pages are the intellectual property of the American College of Medical Toxicology and, RecycleACMT125wthe authors and speakers. No unauthorized download, copy or distribution of these files is permitted.

Click on Color or B&W for the lecture you would like, or right-click and select "Save As..."

Please note that the web-based syllabus will be updated as new or revised material is made available. When re-visiting the syllabus, please refresh your browser to ensure access to recent updates. Breakout sessions may feature handouts that will be made available during individual sessions.

Saturday, March 29, 2014

General Session: Flagstaff/Mesa Ballroom in the Conference Center at the Arizona Biltmore Resort.
Poster Session & Stimulus Room: Casa Grande Ballroom, adjacent the Flagstaff/Mesa Ballroom.
Breakout Workshops & Committee Meeting: Cameron, Prescott and Sedona Rooms in the Conference Center and the Arizona History Room located on the 2nd floor, elevator main lobby.
8:00am-5:00pm Posters on Display
Opening Remarks  
Platform Session 2
Moderators: Jeffrey Brent, MD, PhD, FACMT; Lewis S. Nelson, MD, FACMT

Trends in Opioid Prescribing for Acute Headache in U.S. Emergency Departments
Maryann Mazer-Amirshahi, PharmD, MD
The George Washington University, Washington, DC

Trends in Opioid Prescribing in U.S. Emergency Departments Based on Provider Level of Training
Maryann Mazer-Amirshahi, PharmD, MD
The George Washington University, Washington, DC

A 3-year Analysis and Comparison of Opioid Prescribing Practices by Emergency Care Providers for Chronic Pain
Victoria J. Ganem, RN, BSN
San Antonio Military Medical Center, Fort Sam Houston, TX

Buprenorphine/Naloxone Pediatric Ingestion: Exposure Rates Differ Between Film and Tablet Formulations
Eric J. Lavonas, MD, FACMT
Rocky Mountain Poison and Drug Center, Denver, CO

Buprenorphine/Naloxone Abuse and Diversion: Film Rates are Less Than Tablet Rates
Eric J. Lavonas, MD, FACMT
Rocky Mountain Poison and Drug Center, Denver, CO

Sub-Anesthetic Slow Infusion of Ketamine for Treatment of Depression Produces Rare but Currently Unpredictable and Potentially Serious Psychosomatic Effects
J.J. Rasimas, MD, PhD
Penn State College of Medicine, Hershey, PA

Advanced Neuroimaging and Toxicology
Laura M. Tormoehlen, MD, Indiana University, Indianapolis, IN
Learning Objectives:
  • Discuss interpretation of MRI, specifically FLAIR and Diffusion-weighted imaging.
  • Review MR spectroscopy and its utilization in white matter disease, including toxic leukoencephalopathy.
  • Discuss SPECT imaging in idiopathic and drug-induced parkinsonism.
Presidential Keynote:
Specialty Toxicology Testing: The Interface with The Clinician and the Response to Emerging Drugs of Abuse
Robert Middleberg, PhD, DABFT, DABCC-T, Laboratory Director & Vice President, Quality Assurance, NMS Labs, Willow Grove, PA
Learning Objectives:
  • Balancing the utility, practicality and the cost of specialty toxicology testing.
  • Development of novel assays: the role of the clinician and experience with synthetic cannabinoids.
10:30-10:45am Break  
Casa Grande
Poster Session 1: Authors with Posters
Moderator: Daniel Rusyniak, MD, FACMT
Professional Development Session: Attend 2/3 sessions  
Techno TATS: Tricks, Apps, and Tips
Howard A. Greller, MD, FACMT, Northshore University Hospital, New York, NY
Daniel Rusyniak, MD, FACMT, Indiana University, Indianapolis, IN
Learning Objective:
  • Showcase selected technology tools useful to medical toxicology academic practice.
Medication Safety and Technology: Clarity or Complexity?
Moderator: Lewis S. Nelson, MD, FACMT, New York University, NY
Panelists: Brenna Farmer, MD, Weill-Cornell Medical Center, New York NY; Erica Liebelt, MD, FACMT, University of Alabama-Birmingham, Birmingham, AL; Jeanmarie Perrone, MD, FACMT, University of Pennsylvania, Philadelphia, PA; Silas W. Smith, MD, New York University, New York, NY
Learning Objectives:
  • Case based presentations of technology fixes and failures in the realm of medication safety.

Use of Antivenom for Exotic Envenomations: Clinical, Regulatory, and Practical Considerations

Moderator: Anne Michelle Ruha, MD, FACMT, Banner Good Samaritan Medical Center, Phoenix, AZ

Leslie V. Boyer, MD, FACMT, University of Arizona, Tucson, AZ; C. Drew Foster, The Phoenix Zoo, Phoenix, AZ; Dorothy Scott, MD, US Federal Drug Administration, Silver Spring, MD

Learning Objectives:

  • Discuss how and where to obtain antivenom for exotic envenomations.
  • Discuss how to prepare for an exotic envenomation.
  • Discuss Investigational New Drug Application as it relates to antivenom and how it can be shared between institutions. 
Frank & Albert's
By Invitation
Resident/Student Luncheon: Why Medical Toxicology?
Michele M. Burns, MD, MPH, FACMT, Children's Hospital Boston, Boston, MA
Leslie R. Dye, MD, FACMT, Journal of Medical Toxicology, Waynesville, OH
Louise W. Kao, MD, FACMT, Indiana University, Indianapolis, IN
Fellows-in-Training LuncheonHow Can an MPH Enhance Your Toxicology Career?
Stephen W. Munday, MD, MPH, FACMT, University of California-San Diego, San Diego, CA; Josh G. Schier, MD, MPH, FACMT, Centers of Disease Control and Prevention, Atlanta, GA
Learning Objectives:
  • Discuss how obtaining additional training in public health can enhance your career opportunities as a toxicologist.
  • Discuss the logistics of obtaining an MPH degree and how to integrate this skill set into your medical toxicology practice.
3:00 - 6:00pm Phoenix Herpetological Society optional tour  

Speaker and Organizer Biosketches 


Dr. Leslie V. Boyer is the founding director of the Venom Immunochemistry, Pharmacology and Emergency Response (VIPER) Institute at the University of Arizona. She has been the sponsor, designer, or central principal investigator for 8 multicenter clinical trials of antivenom for treatment of envenomation by vipers, elapids, and arachnids, including study design, network oversight, interface with regulatory authorities including FDA, data analysis and reporting of findings under INDA and BLA. She has developed INDAs for emergency use, shortage preparedness, and formal clinical trials of antivenom. She is the principal architect of the online Antivenom Index, used by US zoos and poison centers to locate critical emergency supplies of rare antivenom products; and she was co-founder of Panamerican Lymphotoxinology Taskforce, promoting multidisciplinary collaborative venom research across institutions in the US and Latin America.


Dr. Michele Burns attended both Emory College and Emory School of Medicine followed by a pediatric residency at the University of Texas Southwestern. She moved to Boston in 1995 for a combined fellowship in Pediatric Emergency Medicine & Medical Toxicology at Children's Hospital Boston. Dr. Burns became the Medical Director of the Poison Control Center for Massachusetts & Rhode Island in 2000 and the Harvard Medical Toxicology Fellowship Director/Chief of the In-Patient Toxicology Program in 2001. She is an Assistant Professor of Pediatrics at Harvard Medical School. She is chair of ACMT’s Education Committee. She is involved with ToxIC (Toxicology Investigator’s Consortium) and is a reviewer for the Journal of Medical Toxicology. She obtained her MPH in Clinical Effectiveness at the Harvard School of Public Health.  


Dr. G. Patrick Daubert is an Army veteran with the 1st Infantry Division and received his undergraduate education in biomedical engineering at The University of Iowa (Go Hawks!). He graduated from St. George’s University School of Medicine following his military service. He completed his internship and residency in Emergency Medicine at Wayne State University/Detroit Medical Center. This was followed by a toxicology fellowship with at the Children’s Hospital of Michigan in Detroit. Dr. Daubert currently works for Kaiser Permanente as part of their Northern California Regional Toxicology Service. He is the past Director of Clinical and Medical Toxicology Education at the University of California, Davis, Medical Center and past Program Director for the Fellowship in Medical Toxicology. He was previously an Associate Medical Director, Sacramento Division, of the California Poison Control System. His areas of interest include pediatric lead poisoning, poisonous plants and fellow-in-training education. In addition, Dr. Daubert is an avid road and mountain cyclist and races/rides off-road motorcycles.


Dr. Brenna M. Farmer is an attending physician and Assistant Professor of Medicine at Weill-Cornell Medicine College and NY Presbyterian Hospital/Weill-Cornell Campus. She is a member of ACMT and chair of ACMT’s Medication Management Section. She serves as co-chair of NY Presbyterian Hospital’s Adverse Drug Reactions Committee and is a member of the Medication Safety Subcommittee and Drug Shortages Committee.  When she is not working clinically in the Emergency Department or as a consultant on the Medical Toxicology Consultation Service, she teaches residents and students about safe medication practices, overdoses, and other toxicology areas of interest including wilderness medicine topics like bites, stings, and plant poisonings. She will complete a “Comprehensive Patient Safety Leadership Fellowship” through the American Hospital Association and National Patient Safety Foundation in June 2013.


C. Drew Foster has been an Animal Curator at the Phoenix Zoo since 2011. Prior to his move to Arizona he served as Collection Manager of Herpetology at the Bronx Zoo.  A lifelong fascination for snakes led Drew to pursue a Bachelor’s of Science in Zoology and a Master’s of Science in Biological Sciences from Eastern Illinois University.  As a professional zoologist with expertise in herpetology, he has many years of experience conducting formal and informal field work as well as in the captive management of herpetofauna. He has worked at four accredited zoological institutions around the country. Drew serves on the Association of Zoos and Aquariums Annual Conference Program Committee and the Program Animal Scientific Advisory Group Steering Committee. He oversaw the exotic venomous program at the Bronx and started the exotic venomous snake program at the Phoenix Zoo. Through these roles, he brings the professional zoo world’s perspective of maintaining foreign antivenin stocks to sustain these programs.


Victoria J. Ganem received a BS in psychology from Texas A&M University and a BS in Nursing from the University of Texas Health Science Center at San Antonio. Prior to focusing on research, she worked as a critical care RN. Her focus areas in research are Emergency Medicine, Opioid Use/Misuse and the En route care of military patients during transport.


Dr. Howard A. Greller received his BA from Yale University and his MD from the New York University School of Medicine. He did his residency in Emergency Medicine at the University of Pennsylvania and completed a fellowship in Medical Toxicology at the New York University School of Medicine / New York City Poison Control Center. Dr. Greller is board certified in medical toxicology and emergency medicine. Currently, Dr. Greller is an assistant professor in the Department of Emergency Medicine at Hofstra North Shore-LIJ School of Medicine.  Dr. Greller has served as a member of the Board of Directors of both the American College of Medical Toxicology and the Medical Toxicology Foundation. He has worked closely with other committee chairs and board members to foster educational goals, such as the Innovative Teaching Award, which is an unrestricted grant for innovations in medical toxicology education. Dr. Greller’s vision is to “make ACMT, and the information possessed by medical toxicologists, more accessible in the world of medicine.”


Dr. Louise Kao received her medical degree from Rush Medical College in Chicago, where she worked as a Poison Information Specialist (PIS) at the Chicago Poison Center under the medical direction of Dr. Jerrold Leikin. Dr. Kao went on to complete residency in Emergency Medicine and a Medical Toxicology Fellowship at Indiana University/Methodist Hospital in Indianapolis. She is board certified in Emergency Medicine and Medical Toxicology. Dr. Kao currently serves as the IU Medical Toxicology Fellowship Director as well as the Director of the Medical Toxicology rotation for residents and students in addition to her clinical Emergency Medicine and Toxicology duties. She is an Associate Professor of Clinical Emergency Medicine at the IU School of Medicine. She has been actively involved in the ACMT Education, Research, and Fellowship Directors committees. Her vision for the future involves expanding the visibility and reach of Medical Toxicology across disciplines.


Dr. Mark Kirk is an emergency physician and medical toxicologist at the University of Virginia in Charlottesville, Virginia. He is Associate Professor in the School of Medicine’s Department of Emergency Medicine and Department of Pediatrics and he serves as the Medical Director for the UVA Medical Simulation Center.  He has extensive clinical experiences in hazardous materials response, mass gathering medicine and disaster medicine including participation in emergency response planning, mass gathering medicine and NDMS Disaster Medical Assistance Team responses.  He is an educator focusing on critical care toxicology, hazardous materials responses and specifically responses to large-scale incidents.  His teaching is focused on tactical aspects of patient care by translating knowledge into critical decision-making skills and actions.  He recently served as a technical expert and advisor to the Department of Homeland Security.


Dr. Eric Lavonas, a native of upstate New York, is the associate director of the Rocky Mountain Poison and Drug Center. After graduating from University of Rochester, he received his medical degree from State University of New York Health Science Center at Syracuse. He completed his residency in Emergency Medicine at Methodist Hospital of Indiana, and completed a fellowship in Medical Toxicology at Carolinas Medical Center. He particularly enjoys collaborative projects; recently, he has been involved with the ILCOR and American Heart Association ALS working groups, the ACEP Clinical Policies Committee, the Undersea & Hyperbaric Medicine sub-board, and the CDC CO poisoning surveillance working group. He has been an ACMT member since 1999. Dr. Lavonas has also chaired the ACMT By-laws committee for 6 years, and currently chairs the Liaison committee.


Dr. Erica Liebelt graduated from Duke University and received her medical degree from University of Cincinnati College of Medicine. She completed her residency in pediatrics at Children’s Hospital Medical Center in Cincinnati, Ohio. Dr. Liebelt went on to complete a fellowship in pediatric emergency medicine at Children’s Hospital in Boston, MA, and a fellowship in medical toxicology and pharmacology at Harvard Medical School and the Massachusetts Poison Control Center. Dr. Liebelt is the Director of Medication Safety at Children's of Alabama in Birmingham and a Professor of Pediatrics and Emergency Medicine at University of Alabama School of Medicine Birmingham. Dr. Liebelt has also served as the Director of the Medical Toxicology Program at the UAB Hospital and Children’s Hospital. She is the Co- Medical Director of the Regional Poison Control Center in Birmingham. Dr. Liebelt has also served on the Medical Toxicology Subboard of the American Board of Emergency Medicine. Dr. Liebelt has served on ACMT’s Executive Committee since 2004. She was Vice President from 2006-2008, and President from 2008-2010.


Dr. Maryann Mazer-Amirshahi is an Assistant Clinical Professor of Emergency Medicine at the George Washington University. She completed her PharmD at the University of the Sciences in Philadelphia, followed by medical school at Temple University. She completed her emergency medicine residency at the Hospital of the University of Pennsylvania and medical toxicology fellowship at the George Washington University, where she also received an MPH focusing on environmental and occupational health. She is board certified in emergency medicine and medical toxicology. She is completing a two-year clinical pharmacology fellowship at Children’s National Medical Center in June 2014. She serves as a toxicology consultant for the Mid-Atlantic Center for Children’s Health and the Environment and the National Capital Poison Center. Her research interests include medication safety and prescription drug abuse. 

Middleberg Dr. Robert Middleberg earned a Ph.D. in Pharmacology from Thomas Jefferson University and a Masters Degree in Chemistry from the University of Pittsburgh. He is a Diplomate of the American Board of Forensic Toxicology (DABFT) and Diplomat in Toxicological Chemistry from the American Board of Clinical Chemistry (DABCC-TC). Dr. Middleberg is an Adjunct Clinical Assistant Professor of Pharmacology at Jefferson Medical College, Thomas Jefferson University. He holds a position on the Board of Directors for the American Board of Forensic Toxicology and is an Inspector for the American Board of Forensic Toxicology—Laboratory Accreditation Program. He is a member of many professional organizations, including the Society of Forensic Toxicologists, The International Association of Forensic Toxicologists, the American Association for Clinical Chemistry, the International Association of Therapeutic Drug Monitoring and Clincal Toxicology and is a fellow of the American Academy of Forensic Sciences and current Chair of the Toxicology Section. Dr. Middleberg is a member of the College of American Pathologists Toxicology Resource Committee and sits on the Editorial Board for the Journal of Forensic Sciences. 

Dr. Stephen Munday completed his Bachelors Degree at the University of Florida in 1983 followed by his M.D. degree at the University of Florida in 1987. He then did a one year Internal Medicine Internship at the Naval Hospital Oakland, California in 1988. He completed a Public Health Residency at the University of California, San Diego in 1995 while concurrently obtaining an MPH in Occupational Health and Epidemiology at San Diego State University. Dr. Munday went on to complete an Occupational & Environmental Medicine residency at the University of California, Irvine while at the same time obtaining an MS in Environmental Toxicology. From 2000 through 2002 he completed a Medical Toxicology fellowship at UCSD. Dr. Munday is a Clinical Assistant Professor at UCSD and is also a Consulting Toxicologist for the California Poison Control System, San Diego Division. Dr. Munday is also the Chief of Environmental and Preventive Medicine at the Sharp Rees-Stealy Medical Group. He has been the Public Health Officer for Imperial County, California since 2004. Dr. Munday was involved in teaching the Agents of Opportunity course as well as the Medical Toxicology Board Review course. He recently joined ACMT’s Education committee and is one of the Directors for the 2012 Medical Toxicology Board Review Course. Dr. Munday serves as Chair of the Membership Committee. Dr. Munday’s vision for the future of ACMT: “I want to strengthen the training opportunities in the occupational aspects of Medical Toxicology for fellows and promote our specialty among the Preventive and Occupational Medicine communities. I hope to do this by improving communication with organizations such as the American College of Occupational and Environmental Medicine (ACOEM).”

Lewis Nelson, MD

Dr. Lewis S. Nelson is currently a Professor of Emergency Medicine at New York University School of Medicine, and is an attending physician at both NYU Medical Center and Bellevue Hospital. He is the Director of the Fellowship in Medical Toxicology at New York University School of Medicine and the New York City Poison Control Center. He is the President of the American College of Medical Toxicology and incoming Chair of the FDA’s Drug Safety and Risk Management Advisory Committee. He is an editor of Goldfrank’s Toxicologic Emergencies, now in its 9th Edition, a major textbook in the field of medical toxicology. He has published over 130 peer-reviewed publications and book chapters, and presents frequently at national and international meetings. The focus of his publications and presentations are medication-related adverse effects, chemical terrorism, and toxicity of abused drugs.

Perrone Dr. Jeanmarie Perrone is a Professor of Emergency Medicine at the University of Pennsylvania and the Director of the Division of Medical Toxicology in the Department of Emergency Medicine with secondary appointments in Pediatrics and Pathology and Laboratory Medicine. Dr. Perrone has studied various aspects of the increasing morbidity and mortality stemming from the prescription drug  epidemic. Her current focus and education initiatives are targeted towards mitigating the adverse effects of opioid diversion and towards public and provider education strategies to enhance safe opioid prescribing. She is active in medication safety and the chair of her insitutional Pharmacy and Therapeutics committee. She has advocated and lectured at the state and national level on the value of Prescription Drug Monitoring Programs and is a voting member of the FDA Drug Safety and Risk Management Advisory Committee.
Rasimas125.jpg Dr. Joseph  J. Rasimas attended the University of Scranton and graduated summa cum laude with degrees in biochemistry, mathematics, and philosophy. He completed the Medical Scientist Training Program at Penn State University, earning a Ph.D. in Chemical Biology (2002) and M.D. (2003). Upon graduation from the Penn State College of Medicine, Dr. Rasimas was honored for excellence in both psychiatry and medical toxicology. He matriculated to psychiatry residency training at the Mayo Clinic in Rochester, Minnesota. Dr. Rasimas received the National Institute of Mental Health (NIMH) Outstanding Resident Award in 2005 and was recognized by the American College of Psychiatrists with the Laughlin Fellowship in 2007. He is a member of a number of academic honor societies as well as the Association for the Advancement of Philosophy and Psychiatry. He has studied psychotherapy at the Minnesota Psychoanalytic Society and Institute and the Washington School of Psychiatry. Dr. Rasimas was a clinical fellow at the NIMH, training in consultation-liaison psychiatry, bioethics, and clinical research. He has served as a staff psychiatrist for Hershey Medical Center and remains an Associate Professor of Psychiatry and Emergency Medicine for the Penn State College of Medicine, there. He completed a medical toxicology fellowship, obtained board certification in Addiction Medicine, and then returned to NIMH to join the Intramural Research Program. Dr. Rasimas is pursuing an academic medical career at the interface of psychosomatic medicine, medical toxicology, and psychodynamic psychotherapy. His primary areas of clinical interest are pharmacotherapeutics, neuropsychiatric toxicity, psychoanalysis, and the phenomenology of suicide.

Dr. Anne-Michelle Ruha received her medical degree from UMDNJ New Jersey Medical School and then completed an Emergency Medicine residency at Morristown Memorial Hospital in New Jersey. Her fellowship training brought her to Phoenix, Arizona, where she continues to serve as Director of the Medical Toxicology Fellowship at Banner Good Samaritan Medical Center.  She is Board Certified in Emergency Medicine and Medical Toxicology but her clinical practice is focused on providing care to poisoned and envenomed patients. She is a Clinical Assistant Professor with the Department of Emergency Medicine at the University of Arizona College of Medicine and also serves on the Medical Toxicology Subboard for the American Board of Emergency Medicine, the certifying organization for medical toxicologists.  Dr. Ruha is an Editorial Board member and the Review Article Editor for the Journal of Medical Toxicology. Her major area of interest and research is in envenomations. Dr. Ruha has been a member of the Board of Directors of the American College of Medical Toxicology since 2009.

Rusyniak Dr. Daniel Rusyniak is the recipient of the 2014 ACMT Outstanding Contribution to Medical Toxicology Research Award. As a college student, he identified halothane's toxic metabolite as trifluoroethanol. As a medical student, he discovered that MDMA caused dopamine toxicity in cultured cells and developed new assays to detect methamphetamine. These early experiences set the stage for a very productive research career focused on amphetamines. Dr. Rusyniak has made major contributions to our understanding of the mechanism by which amphetamines cause life-threatening hyperthermia. While initially a mitochondrial researcher, his studies ultimately showed that hyperthermia from MDMA and methamphetamine was largely centrally-mediated. Further work anatomically pinpointed the dorsomedial hypothalamus as a key locus for both MDMA- and methamphetamine-induced hyperthermia. Notably, the impact of his research has been recognized by NIH with K08 and R01 awards; he is one of only a handful medical toxicologists to have received NIH funding. Dr. Rusyniak is continuously creating new knowledge, currently investigating mechanisms by which amphetamines prevent exhaustion during exercise at high temperatures and elucidating risk factors for exertional heat stroke at competitive events.As Dr. Rusyniak’s own career has advanced, so has his passion for faculty development and mentoring. As Vice Chair of Faculty Development of Emergency Medicine at IU, he has mentored junior faculty members such as Louise Kao, Laura Tormoehlen, and Blake Froberg in the arenas of adolescent opioid toxicity the predictive value of early APAP levels. These were some of the first studies to utilize ToxIC as a multicenter research netwok. He remains involved in the network and has two ongoing studies, one on bath salts and one on synthetic cannabinoids. Beyond his own research findings, we are particularly grateful to Dr. Rusyniak for his other dedicated service that has advanced medical toxicology research as a whole including his service as Chair of the ACMT Research Committee. He is an editorial board member of The Journal of Medical Toxicology (JMT) and a reviewer for several other distinguished journals, and along with Howard Greller serves as co-host of the JMT podcast. He has served on the ACMT and MTF Boards and the ACMT Education Committee and Nominations Committees.
Schier 125w Dr. Joshua G. Schier is board certified in Medical Toxicology and Emergency Medicine and received his MPH in Epidemiology from the Emory Rollins School of Public Health. He is currently the Lead of the Environmental Toxicology Team, in the National Center for Environmental Health at CDC in Atlanta, GA. He is also an Assistant Professor in Emergency Medicine (Medical Toxicology Section) in the Emory University School of Medicine, an Associate Director of the Emory/CDC Medical Toxicology Fellowship, and a Medical Toxicology Attending and Consultant for Grady Health Systems and the GA Poison Center.

Dr. Silas W. Smith is currently an Assistant Professor in the Department of Emergency Medicine at the NYU School of Medicine and Chief of its Section on Quality and Safety. He is also Associate Director of the Fellowship in Medical Toxicology at NYU and the New York City Poison Control Center, and an Attending Physician in Emergency Medicine at the NYU Langone Medical Center and Bellevue Hospital Center. Upon graduating from the Johns Hopkins University School of Medicine, Dr. Smith served on active duty for five years in the U.S. Navy, deploying abroad as a Naval Flight Surgeon. He returned to NYU/Bellevue Hospital Center to complete his residency in Emergency Medicine and fellowship in medical toxicology at New York University and the New York City Poison Control Center. He has previously served as a subject matter expert for a Department of Homeland Security model of chemical terrorism risk assessment, and collaborated on federally funded projects focusing on computer simulation for consequence assessment of large scale chemical terrorism; hospital-based biological, chemical, tactical pharmaceuticals, and radiological hazards; and novel technology for stand-off diagnosis of pandemic respiratory illness.


Dr. Laura Tormoehlen is an Assistant Professor of Clinical Neurology and Emergency Medicine at Indiana University (IU).  She completed her medical degree, as well as her neurology residency and medical toxicology fellowship, at IU.  Dr. Tormoehlen is board-certified in Neurology and Medical Toxicology.  She is an attending physician and Director of Inpatient Neurology Services at Methodist Hospital in Indianapolis and leads a Neurology teaching service.  She also attends the Medical Toxicology consult service on a part-time basis.  Her educational endeavors include teaching neuropharmacology to the neurology residents and toxicology fellows, as well as lecturing to emergency medicine, neurology, psychiatry, internal medicine, and critical care physicians on neurotoxicology topics.